Surgical resection post-systemic therapy for hepatocellular carcinoma (HCC) yields encouraging long-term outcomes. In a cohort of 96 patients, median overall survival reached four years, with one-year survival rates at 86.1%. R0/R1 resection correlated with improved progression-free and overall survival, presenting a significant therapeutic advantage. Complications were manageable, with no 30-day mortalities and a 4.2% rate at 90 days. This approach refines treatment strategies for advanced HCC patients.
Journal Article by Ishii T, Shindoh J (…) Hatano E et 14 al. in Hepatol Res
© 2025 Japan Society of Hepatology.